Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

PT-141 Reconstitution: Concentration vs Shelf Life Comparison

1mL per 10mg 14–21 days <6 hours Maximum potency per volume but shortest stability. Use for single-week protocols only 2mL per 10mg 28 days <12 hours Standard research concentration. Optimal balance of dosing precision and multi-week stability 5mL per 10mg 35

This comparison does not assign a generated winner or score.

  • 1mL per 10mg
  • 14–21 days
  • <6 hours
  • Maximum potency per volume but shortest stability. Use for single-week protocols only
  • 2mL per 10mg
  • 28 days
  • <12 hours
  • Standard research concentration. Optimal balance of dosing precision and multi-week stability
  • 5mL per 10mg
  • 35 days
  • <18 hours
  • Lowest concentration extends shelf life but requires larger injection volumes that increase dead space loss
  • 2.5mg/mL
  • 4mL per 10mg
  • 0.8mL (80 units)
  • 30–32 days
  • <15 hours
  • Compromise ratio. Slightly longer stability than 5mg/mL without requiring full 1mL injections
More references

Related material

Comparison

Nasal Spray vs Injection

PT-141 nasal spray is available from compounding pharmacies but was rejected by the FDA for good reason. Diamond et al. (2004, PMID: 14963471) studied intranasal bremelanotide and…

View details →